Featured Research

from universities, journals, and other organizations

Researchers Identify Gene For A Primary Form Of Sudden Infant Death Sydrome (SIDS)

Date:
July 20, 2004
Source:
The Translational Genomics Research Institute
Summary:
Scientists at the Translational Genomics Research Institute (TGen), Phoenix, Arizona, and the Clinic for Special Children, Strasburg, Pennsylvania, have found the genetic basis for one form of sudden infant death syndrome (SIDS).

PHOENIX, July 19, 2004 — Scientists at the Translational Genomics Research Institute (TGen), Phoenix, Arizona, and the Clinic for Special Children, Strasburg, Pennsylvania, have found the genetic basis for one form of sudden infant death syndrome (SIDS). The researchers have named the newly described form as sudden infant death with dysgenesis of testes, or SIDDT. The finding, released this week on-line by the journal Proceeding of the National Academy of Sciences could provide new insight into the inexplicable, sudden deaths of some 3,000 infants a year in the US.

SIDS has long been a catchall term for infants that die unexpectedly of unknown causes before their first birthday. By discovering a gene linked to some of these deaths, a team of researchers led by Dr. Dietrich Stephan, director of neurogenomics at TGen, and the paper's senior author, has begun to expose the distinct genetic causes behind these deaths.

"This is one of the first genetic sub-classifications of SIDS," Stephan said. "And it's going to be helpful in offering parents answers for sudden infant deaths, recognizing predisposition early, and hopefully saving a number of these babies."

The researchers first identified patients with SIDDT in a small Old Order Amish community in central Pennsylvania. Over two generations, nine families from this community had lost twenty-one infants to this sudden death syndrome. This familial clustering suggested a genetic basis for the syndrome. All infants with SIDDT died before 12 months of age of abrupt cardiac and respiratory arrest. While many of these infants underwent testing at major medical centers, no abnormalities were found. Males with SIDDT may also have underdeveloped testes. Females appear to be normal and have normal female hormones in blood and urine. Despite these differences, male and female infants with SIDDT died suddenly at the same age.

The researchers analyzed the DNA from four of these infants, along with their parents, siblings, and extended family members. Using Affymetrix SNP arrays -which examine 11,555 single letter, or nucleotide, variations in the genome known as single nucleotide polymorphisms-the researchers narrowed the location of the disorder to a region on chromosome 6. By correlating the genes known to reside in the region with their clinical understanding of the syndrome, the researchers believed a gene called TSPYL, which is expressed both in the brainstem and in testes, might be responsible for the sudden deaths in these infants. DNA sequencing of this gene in all four patients revealed a severe alteration. All affected infants were found to have two abnormal copies of the TSPYL gene and all parents were carriers of the alteration. Although several other genes are known to be associated with SIDS, this is the first gene identified which causes a primary form of SIDS.

"This study provides new insight into how the nervous system is regulated and highlights the benefits of close collaborations between researchers, physicians, and the patients they care for," said Dr. Erik G. Puffenberger, Laboratory Director at the Clinic for Special Children, the paper's first author.

The discovery also demonstrates the rapidly increasing speed of modern medical research. The mapping and identification of the gene was performed in less than two months from start to finish.

According to the physicians at the Clinic for Special Children, SIDDT is a new disease that has never been described before. The alteration in TSPYL can affect the neurological system and cause sudden death, and in males can also affect the reproductive system. According to Stephan, the relationship of TSPYL mutations or polymorphisms to SIDS in the general population will be studied next. Future work will examine the effects of this gene on the normal control of breathing and heart rate in otherwise normal, premature infants. The gene may be used as a diagnostic marker and to develop treatments.

"This collaboration between the Clinic for Special Children, Translational Genome Research Institute (TGEN), and Affymetrix is an important example of how modern genetic knowledge can, and should be, used to help solve medical problems," said Dr. D. Holmes Morton, Director of the Clinic for Special Children.

###

About TGen

TGen is a not-for-profit research institute whose primary mission is to make and translate genomic discoveries into advances in human health. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project to apply to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. For additional information, please visit the TGen web site at http://www.tgen.org.

About The Clinic for Special Children

The Clinic for Special Children is a non-profit diagnostic and pediatric medical service for children with genetic disorders in Lancaster County, PA. The clinic was established to provide comprehensive medical care and affordable diagnostic and laboratory services for children with chronic, complex health problems due to inherited disorders. The mission of the clinic also includes improving newborn screening and follow-up services, developing more effective diagnostic methods, advancing clinical research, and acting as an educational resource for those who seek to provide care for children who suffer from rare, inherited diseases.

About Affymetrix

Affymetrix is a pioneer in creating breakthrough tools that are driving the genomic revolution. By applying the principles of semiconductor technology to the life sciences, Affymetrix develops and commercializes systems that enable scientists to improve quality of life. The Company's customers include pharmaceutical, biotechnology, agrichemical, diagnostics and consumer products companies as well as academic, government and other non-profit research institutes. Affymetrix offers an expanding portfolio of integrated products and services, including its integrated GeneChip brand platform, to address growing markets focused on understanding the relationship between genes and human health. Additional information on Affymetrix can be found at http://www.affymetrix.com.


Story Source:

The above story is based on materials provided by The Translational Genomics Research Institute. Note: Materials may be edited for content and length.


Cite This Page:

The Translational Genomics Research Institute. "Researchers Identify Gene For A Primary Form Of Sudden Infant Death Sydrome (SIDS)." ScienceDaily. ScienceDaily, 20 July 2004. <www.sciencedaily.com/releases/2004/07/040720091826.htm>.
The Translational Genomics Research Institute. (2004, July 20). Researchers Identify Gene For A Primary Form Of Sudden Infant Death Sydrome (SIDS). ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2004/07/040720091826.htm
The Translational Genomics Research Institute. "Researchers Identify Gene For A Primary Form Of Sudden Infant Death Sydrome (SIDS)." ScienceDaily. www.sciencedaily.com/releases/2004/07/040720091826.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins